Smart Grid Update; Notice of Commissioner and Staff Attendance at FERC/NARUC Collaborative on Smart Response Meeting, 42747 [2010-17888]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 140 / Thursday, July 22, 2010 / Notices
Issued in Golden, CO on July 15, 2010.
Jamie Harris,
Director, Office of Acquisition and Financial
Assistance, Golden Field Office.
[FR Doc. 2010–17987 Filed 7–21–10; 8:45 am]
BILLING CODE 6450–01–P
DEPARTMENT OF ENERGY
Federal Energy Regulatory
Commission
[Docket No. AD10–15–000]
Smart Grid Update; Notice of
Commissioner and Staff Attendance at
FERC/NARUC Collaborative on Smart
Response Meeting
July 15, 2010.
The Federal Energy Regulatory
Commission hereby gives notice that
members of the Commission and/or
Commission staff may attend the
following meeting:
FERC/NARUC Collaborative on Smart
Response: Sacramento Convention
Center, 1400 J Street, Sacramento, CA
95814. July 18, 2010 (8:15 a.m.–12:30
p.m.)
Further information may be found at
https://summer.narucmeetings.org/
program.cfm.
Kimberly D. Bose,
Secretary.
[FR Doc. 2010–17888 Filed 7–21–10; 8:45 am]
BILLING CODE 6717–01–P
ENVIRONMENTAL PROTECTION
AGENCY
[FRL–9178–4]
Protection of Stratospheric Ozone:
Request for Applications for Essential
Use Allowances for 2012 and 2013
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
sroberts on DSKD5P82C1PROD with NOTICES
Table of Contents
The Environmental Protection
Agency is requesting applications for
essential use allowances for calendar
years 2012 and 2013. Essential use
allowances provide exemptions from
the phaseout of production and import
of ozone-depleting substances. Essential
use allowances must be authorized by
the Parties to the Montreal Protocol on
Substances that Deplete the Ozone
Layer. The U.S. Government will use
the applications received in response to
this notice as the basis for its
nomination of essential uses at the 23rd
Meeting of the Parties to the Protocol, to
be held in 2011.
SUMMARY:
VerDate Mar<15>2010
18:46 Jul 21, 2010
Jkt 220001
Applications for essential use
allowances must be submitted to EPA
no later than August 23, 2010 in order
for the U.S. Government to complete its
review and to submit nominations to the
United Nations Environment
Programme and the Protocol Parties in
a timely manner.
ADDRESSES: Send application materials
to: Jeremy Arling, Stratospheric
Protection Division (6205J), U.S.
Environmental Protection Agency, 1200
Pennsylvania Avenue, NW.,
Washington, DC 20460. For applications
sent via courier service, use the
following direct mailing address: 1310 L
Street, NW., Washington, DC 20005,
room 1047E.
Confidentiality: Application materials
that are confidential should be
submitted under separate cover and be
clearly identified as ‘‘trade secret,’’
‘‘proprietary,’’ or ‘‘company
confidential.’’ Information covered by a
claim of business confidentiality will be
treated in accordance with the
procedures for handling information
claimed as confidential under 40 CFR
part 2, subpart B, and will be disclosed
only to the extent and by means of the
procedures set forth in that subpart.
Please note that data will be presented
in aggregate form by the United States
as part of the nomination to the Parties.
If no claim of confidentiality
accompanies the information when it is
received by EPA, the information may
be made available to the public by EPA
without further notice to the company
(40 CFR 2.203).
FOR FURTHER INFORMATION CONTACT:
Jeremy Arling at the above address, or
by telephone at (202) 343–9055, by fax
at (202) 343–2338, or by e-mail at
arling.jeremy@epa.gov. Information
about essential uses may be obtained
from EPA’s stratospheric protection
Web site at https://www.epa.gov/ozone/
title6/exemptions/essential.html.
SUPPLEMENTARY INFORMATION:
DATES:
I. Background on the Essential Use
Nomination Process
II. Information Required for Essential Use
Applications for Production or Import of
Class I Substances in 2012 and 2013
I. Background on the Essential Use
Nomination Process
The Parties to the Protocol agreed
during the Fourth Meeting in
Copenhagen on November 23–25, 1992,
that non-Article 5 Parties (developed
countries) would phase out the
production and consumption of halons
by January 1, 1994, and the production
and consumption of other class I
substances (under 40 CFR part 82,
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
42747
subpart A), except methyl bromide, by
January 1, 1996. The Parties also
reached decisions and adopted
resolutions on a variety of other matters,
including the criteria to be used for
allowing ‘‘essential use’’ exemptions
from the phaseout of production and
import of controlled substances.
Decision IV/25 of the Fourth Meeting of
the Parties details the specific criteria
and review process for granting
essential use exemptions.
Decision IV/25, paragraph 1(a), states
that ‘‘* * * a use of a controlled
substance should qualify as ‘essential’
only if: (i) It is necessary for the health,
safety or is critical for the functioning of
society (encompassing cultural and
intellectual aspects); and (ii) there are
no available technically and
economically feasible alternatives or
substitutes that are acceptable from the
standpoint of environment and health.’’
In addition, the Parties agreed ‘‘that
production and consumption, if any, of
a controlled substance, for essential uses
should be permitted only if: (i) All
economically feasible steps have been
taken to minimize the essential use and
any associated emission of the
controlled substance; and (ii) the
controlled substance is not available in
sufficient quantity and quality from the
existing stocks of banked or recycled
controlled substances * * *’’ Decision
XII/2 of the Twelfth Meeting of the
Parties states that any CFC metered dose
inhaler (MDI) product approved after
December 31, 2000, is nonessential
unless the product meets the criteria in
Decision IV/25, paragraph 1(a).
The first step in obtaining essential
use allowances is for the user to
consider whether the use of the
controlled substance meets the criteria
of Decision IV/25. If the essential use
request is for an MDI product, the user
should also consider whether the
product meets the criteria of Decision
XII/2. In addition, the user should
consult recent and ongoing rulemakings
by the Food and Drug Administration
(FDA) concerning the essential use
determination of various MDI moieties.
In particular, users should consider
FDA’s November 19, 2008, final
rulemaking that removes the essential
use designation for epinephrine used in
MDIs as of December 31, 2011 (73 FR
69532). Users should also consider
FDA’s April 14, 2010, rulemaking that
removes the essential use designations
for flunisolide, triamcinolone,
metaproterenol, pirbuterol, albuterol
and ipratropium in combination,
cromolyn, and nedocromil used in MDIs
at various dates depending upon the
inhaler (75 FR 19213).
E:\FR\FM\22JYN1.SGM
22JYN1
]]>Agencies
[Federal Register Volume 75, Number 140 (Thursday, July 22, 2010)]
[Notices]
[Page 42747]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-17888]
-----------------------------------------------------------------------
DEPARTMENT OF ENERGY
Federal Energy Regulatory Commission
[Docket No. AD10-15-000]
Smart Grid Update; Notice of Commissioner and Staff Attendance at
FERC/NARUC Collaborative on Smart Response Meeting
July 15, 2010.
The Federal Energy Regulatory Commission hereby gives notice that
members of the Commission and/or Commission staff may attend the
following meeting:
FERC/NARUC Collaborative on Smart Response: Sacramento Convention
Center, 1400 J Street, Sacramento, CA 95814. July 18, 2010 (8:15 a.m.-
12:30 p.m.)
Further information may be found at https://summer.narucmeetings.org/program.cfm.
Kimberly D. Bose,
Secretary.
[FR Doc. 2010-17888 Filed 7-21-10; 8:45 am]
BILLING CODE 6717-01-P
